ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Episode 2: Novel treatments for COVID-19"
Episode Synopsis
Soon after the pandemic started, more than half a million dollars was rapidly reallocated to supply 13 interdisciplinary teams with immediate funding to pursue basic science, technology, clinical or population-based research projects that directly address COVID-19.
Dr. Jianqin Lu, BIO5 member and assistant professor in the College of Pharmacy, discusses his two BIO5 COVID-19 seed grant projects. The first focuses on the use of nanotechnology to improve efficacy and minimize toxicity of anti-malarial drugs against COVID-19, while the second project explores whether enhancing COVID-19 patients’ immune systems can treat their infections.
Dr. Jianqin Lu, BIO5 member and assistant professor in the College of Pharmacy, discusses his two BIO5 COVID-19 seed grant projects. The first focuses on the use of nanotechnology to improve efficacy and minimize toxicity of anti-malarial drugs against COVID-19, while the second project explores whether enhancing COVID-19 patients’ immune systems can treat their infections.
More episodes of the podcast Science Talks
Episode 62: Reflections and horizons at BIO5
17/12/2024
In God we trust